Use of intensive care in patients with nonresectable lung cancer

Chest

Volumn 139, Issue 1, 2011, Pages 101-108

  Toffart, Anne Claire ^a   Minet, Clémence ^a   Raynard, Bruno ^b   Schwebel, Carole ^a   Hamidfar Roy, Rebecca ^a   Diab, Samia ^a   Quetant, Sébastien ^a   Moro Sibilot, Denis ^a,c   Azoulay, Elie ^c,d   Timsit, Jean François ^a,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSERM   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; FEMALE; FRANCE; HAZARD RATIO; HUMAN; INTENSIVE CARE UNIT; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 78651423038     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2863     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. Reck M, von Pawel J, Zatloukal P, et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol. 2009;27(8):1227-1234.
3. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al; National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005;353(2):123-132.
4. Garrouste-Orgeas M, Montuclard L, Timsit JF, et al; French ADMISSIONREA Study Group. Predictors of intensive care unit refusal in French intensive care units: a multiple-center study. Crit Care Med. 2005;33(4):750-755.
5. Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. Intensive care, survival, and expense of treating critically ill cancer patients. JAMA. 1993;269(6):783-786. (Pubitemid 23039087)
6. Soubani AO, Adam AK. Medical intensive care for lung cancer patients: better than we thought? Future Oncol. 2008;4(2):141-144.
7. Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 2001;29(2):277-282.
8. Naruke T, Tsuchiya R, Kondo H, Asamura H, Nakayama H. Implications of staging in lung cancer. Chest. 1997;112(4 suppl):242S-248S.
9. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-655.
10. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957-2963. (Pubitemid 24000804)
11. Le Gall JR, Klar J, Lemeshow S, et al; ICU Scoring Group. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. JAMA. 1996;276(10):802-810.
12. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Control. 1974;AC-19:716-723.
13. Adam AK, Soubani AO. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit. Eur Respir J. 2008;31(1):47-53.
14. Soares M, Darmon M, Salluh JI, et al. Prognosis of lung cancer patients with life-threatening complications. Chest. 2007;131(3):840-846.
15. Reichner CA, Thompson JA, O'Brien S, Kuru T, Anderson ED. Outcome and code status of lung cancer patients admitted to the medical ICU. Chest. 2006;130(3):719-723.
16. Boussat S, El'rini T, Dubiez A, Depierre A, Barale F, Capellier G. Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med. 2000;26(12):1811-1816.
17. Ewer MS, Ali MK, Atta MS, Morice RC, Balakrishnan PV. Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA. 1986;256(24):3364-3366.
18. Pène F, Percheron S, Lemiale V, et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med. 2008;36(3):690-696.
19. Jennens RR, Rosenthal MA, Mitchell P, Presneill JJ. Outcome of patients admitted to the intensive care unit with newly diagnosed small cell lung cancer. Lung Cancer. 2002;38(3):291-296.
20. Azoulay E, Moreau D, Alberti C, et al. Predictors of shortterm mortality in critically ill patients with solid malignancies. Intensive Care Med. 2000;26(12):1817-1823.
21. Thyrault M, Oppon J, Le Bourdiec S, Raynard B, Nitenberg G. Resuscitation management of patients with primary bronchopulmonary cancer [in French ]. Presse Med. 2002;31(31): 1446-1450.
22. Toffart AC, Pluquet E, Timsit JF, Diab S, Moro-Sibilot D. Bronchial carcinoma and intensive care [in French]. Rev Pneumol Clin. 2008;64(5):250-256.
23. Christodoulou C, Rizos M, Galani E, Rellos K, Skarlos DV, Michalopoulos A. Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU). Anticancer Res. 2007;27(4C):2945-2948.
24. Lilenbaum RC, Cashy J, Hensing TA, Young S, Cella D. Prevalence of poor performance status in lung cancer patients: implications for research. J Thorac Oncol. 2008;3(2):125-129.
25. Moro-Sibilot D, Pluquet E, Zalcman G, et al. What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer [in French]? Rev Mal Respir. 2007;24(8 pt 2):6S120-6S 124.
26. Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B. Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer. 1997;33(7):1031-1037.
27. Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A. Predicting survival in patients with advanced disease. Eur J Cancer. 2008;44(8):1146-1156.
28. Maltoni M, Caraceni A, Brunelli C, et al; Steering Committee of the European Association for Palliative Care. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23(25):6240-6248.
29. Staudinger T, Stoiser B, Müllner M, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28(5):1322-1328.
30. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320(7233):469-472.
31. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med. 2001;29(3):519-525.
32. Cuomo A, Delmastro M, Ceriana P, et al. Noninvasive mechanical ventilation as a palliative treatment of acute respiratory failure in patients with end-stage solid cancer. Palliat Med. 2004;18(7):602-610.
33. Kongsgaard UE, Meidell NK. Mechanical ventilation in critically ill cancer patients: outcome and utilisation of resources. Support Care Cancer. 1999;7(2):95-99.
34. Schönfeld N, Timsit JF. Overcoming a stigma: the lung cancer patient in the intensive care unit. Eur Respir J. 2008;31(1):3-5.